About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
Stroke is a medical emergency and a leading cause of death and disability worldwide affecting millions of subjects. In this context the Neurovascular Research Laboratory was created in 2001 focused in stroke research from a basic and translational perspective, covering all stages of the disease: from prevention and treatment, to recovery.
Nowadays our team is composed by a highly motivated group of researchers including clinical and basic scientists, with group leaders involved in National and International projects with public or private research funding on biomarkers for clinical decision making in stroke, the presence of silent infarctions, the assessment of cognition and cognitive decline, developing experimental models of cerebral ischemia testing new treatments complementary to reperfusion, and developing studies on cerebral amyloid angiopathy, tissue neurorepair or post-stroke rehabilitation.
Complementary studies on vascular dementia and Alzheimer disease related to amyloid-beta protein have also been encompassed as part of our research in the last years.
The use of plasma biomarkers is becoming increasingly popular in several fields of medicine. In fact, decision-making processes using biomarkers is widely accepted in medical situations such as initiating lipid lowering therapies (LDL), diagnosing acute myocardial infarction (troponins), and ruling out pulmonary embolism suspicions (D-dimer), among others.
Therefore we really believe that biochemical markers of stroke, will really open “a window to the brain…”. In fact, in this research line we aim to answer relevant clinical questions through the use of biomarkers.
Our main Objectives using mainly plasma proteins are:
1.- To predict stroke risk
2.- To make stroke diagnosis
3.- To differentiate stroke subtypes
4.- To establish evolution and prognosis
5.- To use Biomarkers as treatment end-points
Some of our findings might have therapeutic implications since biological markers described by the group such as MMP-9 are well associated with Blood Brain Barrier disruption. In this direction, we have described MMP-9 predicting haemorrhagic complications among stroke patients receiving thrombolytic treatment. These approaches might contribute to increase safety of reperfusion treatments. The impact of this research line is clear, since articles like this (Circulation 2003) have been cited more than 180 times since its publication.
The study of these molecules will also have diagnostic implications because we have proposed the biochemical diagnostic of stroke by means of the identification of a biomarkers panel that distinguish between a stroke and other stroke-mimicking conditions. This might contribute to refer only to real stroke patients to the stroke centres, saving huge resources to the system.
These two examples, identification of biomarkers to predict tPA related bleedings and a stroke diagnostic test are examples of translational research in which the Neurovascular Research Lab is filing patents to be licensed to Biotech companies able to develop diagnostic kits in which our biomarkers might be placed and used in the clinical practice. That might close the circle of applied research.
Reviews of our group in which you may find detailed info about those biomarkers:
Foerch C, Montaner J, Furie KL, Ning MM, Lo EH.
Searching for oracles? Blood biomarkers in acute stroke
Neurology. 2009;73(5):393-9.
Montaner J.
Blood biomarkers to guide stroke thrombolysis.
Front Biosci (Elite Ed). 2009 Jun 1;1:200-208.
García-Berrocoso T, Fernández-Cadenas I, Delgado P, Rosell A, Montaner J.
Blood Biomarkers to Identify Stroke Etiologies.
Therapy 2010 (in press).
Projects
We are involved in several projects with public or private funding supporting our research on stroke biomarkers. One of such exciting projects is FIS PI 08/361 “Identificación y uso de biomarcadores pronósticos en el ictus isquémico”, aiming to identify biomarkers that predict main causes of stroke worsening (Infarct growth, cardiac complications, hemorrhagic transformation, infections, recurrence or new vascular events) to guide Stroke Unit allocation and stay of our patients.
International Collaborations
Discovery and validation of good candidate biomarkers, requires multidisciplinary approaches and replication in well designed multicentric and international studies. For that purpose we are actively collaborating with well known stroke research leading groups:
- Eng Lo, Xiaoing Wang, Ming Ming Ning (Boston, USA).
- Jean Charles Sanchez, Natacha Turck (Geneva, Switzerland).
- Denis Vivien, Carine Ali, Eduardo Anglés-Cano (Caen, France).
Research Tools and Techniques
We are using a combination of discovery techniques and biological human and animal samples to identify new stroke-related biomarkers:
One example is the “protein arrays”. In our laboratory, we have been using these new technologies and we actually use the SearchLight Assays (Aushon Biosystems) that allows us to study more than 170 human proteins and also many candidates from different animal species. We offer access to our technology to other groups. For more information, please refer to http://www.lin-bcn.com/
Also those biomarkers may be specifically tested not only as circulating markers in plasma or serum but in the components of interest of the Neurovascular Unit, that we may dissect by using the LCM Leica LMD6000 microscope, for Laser Capture microdissection. An example in which combine both thecniques may be found at:
Cuadrado E, Rosell A, Penalba A, Slevin M, Alvarez-Sabin J, Ortega-Aznar A, Montaner J. Vascular MMP-9/TIMP-2 and neuronal MMP-10 up-regulation in human brain after stroke: a combined Laser Microdissection and Protein Array Study. Journal of Proteome Research 2009;8(6):3191-3197.
Biobanks
All these results have been possible since the development of a “blood library” including more than 2000 stroke samples and a “brain library” that allowed us to describe for the first time the “human stroke proteome” with the outstanding collaboration of so many patients, relatives and clinicians of the Stroke Unit.
IP: Joan Montaner Villalonga, Anna Penalba Morenilla
BACKGROUND
The only approved stroke treatment so far is the acute thrombolytic therapy with recombinant tissue plasminogen activator (rt-PA) when administered within 3-4.5 hours after symptoms onset. However, a reduced number of patients (5-8%) profit by this treatment, primarily because of the narrow therapeutic time-window and the risk of brain bleedings beyond thromrbolytic therapy to achieve the recanalization of the occluded artery. Moreover, the inflammatory response that accompanied necrotic brain injury contributes to aggravate acutely the progression of ischemic pathology. Inflammatory and brain damaged cells release a variety of cytotoxic agents including cytokines, MMPs and ROS which induce more cell damage as well as disruption of BBB and brain edema.
Thereby, it would be desirable to improve the efficacy and safety for thrombolytic therapy of stroke using combined anti-inflammatory strategies that may ameliorate the ischemic injury and means the best therapy translated at the clinical level.
Our research, conducted on experimental models of cerebral ischemia, is focused on the development of neuroprotective strategies aimed to salvage ischemic brain tissue by means complementary to reperfusion. Our goal is to find out a multimodal treatment that combines the administration of tPA together with other co-agents (as simvastatin and/or anti-aggregants with anti-inflammatory and neuro-protective properties) in attempt to obtain the most therapeutic benefice in the acute phase of ischemic stroke.
EXPERIMENTAL MODELS AND TECHNIQUES
Ischemic stroke has a complex pathophysiology involving the interplay of many different cells and tissues. Animal models of ischemic stroke are procedures inducing cerebral ischemia, which mimicked satisfactorily this cerebrovascular disease. Therefore, research stroke conducted on animal models has been shown essential for treatment approach of ischemic stroke.
Intra-arterial Suture Occlusion Model of Focal Cerebral Ischemia
Infarction in the territory of the middle cerebral artery (MCA) is induced by extracranial vascular occlusion on rat. A heat-blunted 4/0 nylon-monofilament is used to block the origin of MCA during 90 or 120 min and then, the monofilament is removed and reperfusion is allowed during the followed 24, 48 or 72 h.
This model mimics a clinical situation where recanalization of the occluded artery takes place, allowing test neuroprotectants that could be potentially co-administered with reperfusion agents like tPA.
Embolic Model of Focal Cerebral Ischemia
The stroke animal model by clot embolism has a large scientific interest in the clinical field because the high incidence of human thrombotic stroke and the use of reperfusion therapy with tPA, which can be assay on this model. Thromboembolic occlusion at the proximal level of MCA is achieved by injection of a rich fibrin clot through the internal carotid artery in the rat. Clots are previously performed using arterial blood from a donor rat. Thrombolytic therapy with tPA (9 mg/Kg) is administered by tail vein infusion (2 mg/mL;75 ?l/min) at different times points (2, 3, 4 hours) after occlusion.
Relative Cerebral Blood Flow (rCBF) is measured in the cortex supplied by the MCA by continuous Laser Doppler flowmetry (LDF) to ensure the successful of the artery occlusion or reperfusion in these models. To examine the grade of infarction on rats, analysis of the infarct volume is evaluated using 2,3,5-triphenyltetrazolium chloride (TTC) staining and neurological score is assayed with a 9-point neurological at baseline (1-2 h) and each 24 h after occlusion.
NMR Imaging
Bruker-BIOSPEC 70/30 USR, 7 T Preclinical MRI System is used for the neuroimaging studies. Neuroimaging studies are conducted in vivo to valuate the cytotoxic edema and ischemic lesion (DWI, ADC map and T2WI) in the acute phase. Specific sequences are performed to assess Brain-Blood Barrier disruption (DCE) and occurrences of intracranial hemorrhages (T2*WI). Angiography is performed to document MCA occlusion or recanalization.
IP: Joan Montaner Villalonga
New therapies beyond the hyperacute phase of stroke are needed to be able to treat much more patients in delayed phases of this devastating disease. The idea that neurovascular plasticity contributes to stroke recovery can be a powerful concept for stroke therapy. Obviously, the therapeutic time window for interventions based on promoting recovery would be much larger than those for targeting acute stroke. In this context, long-term neuroreparative therapies will have to target the two essential phenomena to achieve brain neurorecovery after stroke: to restore the cerebral blood flow and to promote Neuroregeneration.
To achieve these major goals, both angiogenesis and neurogenesis need to be enhanced in the ischemic brain.
Classically, the formation of new blood vessels was thought to be mediated exclusively by embryogenic vasculogenesis followed by the sprouting of endothelial cells from preexisting vessels during angiogenesis. In the last decade, this standard dogma was overturned with the identification of the existence of circulating bone marrow-derived endothelial progenitor cells (EPCs). These cells are capable of differentiating, ex vivo, into endothelial-phenotyped cells, and now comprise a new model for endothelial generation and vessel repair (Asahara et al., 1997). These cells comprise a potential cell-based and growth-factor source of an alternate approach to enhance angio-neurogenic responses. In fact, newborn neurons (neurogenesis) and new vascular components (angiogenesis) form a microenvironment that has been termed the neurovascular niche [Ohab et al., 2006] were angiogenesis and neurogenesis are linked thorough specific growth factors.
Angiogenesis and neurogenesis occur endogenously after stroke. Our goal is to study these two complex phenomena both in experimental and human studies to finally potentiate them correctly to improve brain function and neurorecovery after stroke.
Experimental Models and Techniques
In vivo stroke models:
Cerebral ischemia affecting the cortical territory of the Middle Cerebral Artery (MCA) is occluded at the level of the M1 portion (distal occlusion). This model has been chosen because presents very low mortality rates allowing long-term studies. Besides, the infarct is restricted to the cortex with clear boundary areas with normal cerebral blood flow and never affects neuroblast-rich areas such as the subventricular zone (then, both angiogenesis and neurogenesis can occur).
Functional outcome is assessed by the cylinder and corner tests which have been reported to be appropriate test for this type of cortical infarcts. Besides, histology and immunohistochemistry studies are conducted to evaluate brain repair and angio-neurogenic processes.
Endothelial Progenitor Cell Cultures:
EPCs are obtained from the Mononuclear cell fraction of human blood and from mouse spleen. MNCs are cultured in fibronectin-coated plates with complete cell culture medium EGM-2MV.
Both in human and murine cell cultures yield an early EPC population (also called Circulating Angiogenic Cells) obtained at day 4-7 after plating and late outgrowth EPC colonies (also called Endothelial Colony Forming Cells) appear from day 10 as colonies with high proliferation capacity and tubulogenic capacity.
In vitro Oxygen-Glucose Deprivation: endothelial cells and Endothelial progenitor cells are challenged to a transitory Oxygen and Glucose deprivation to study their angio-vasculogenic responses to ischemia and to test how potential treatments that could modify these responses.
Angiogenesis-related techniques: angio-vasculogenic mechanisms are studied in a variety of in vitro assays including Matrigel® tubulogenesis, cell migration using trans-well assays or cell adhesion to a mature monolayer of endothelial cells. Our studies focus on the angio-vasculogenic responses of both Endothelial Progenitor Cells and mature endothelial cells such as the human cell line of microvascular endothelial cells (hCMEC/D3).
NMR Imaging: Bruker-BIOSPEC 70/30 USR, 7 T Preclinical MRI System is used for the neuroimaging studies. Neuroimaging studies are conducted in vivo to follow-up the ischemic lesion. Specific sequences are performed to assess axonal degeneration/regeneration and changes in cerebral blood flow and angiogenesis.
IP: Anna Rosell Novel
Current project:
Involment of proteolytic systems in the progression of Cerebral Amyloid Angiopathy
Cerebral amyloid angiopathy (CAA) is produced by the accumulation of ß-amyloid protein within the meningeal and brain vessels. It is the second leading cause of cerebral hemorrhages. However, nowadays, factors related to brain bleedings following amyloid deposition are largely unknown. The understanding of the mollecular mechanisms that lead to cerebral hemorrhage may be the basis for future treatments.
Previous evidences of our group have shown that Matrix Metal•loproteinases (MMPs) are related to brain bleeding. Now, we aim to investigate the relationship between these proteolytic systems and the appearance of intracraneal hemorrages in CAA.
Our study includes:
1) The identification of both tissue and plasma biomarkers for the diagnosis and prognosis of CAA-related hemorrhages.
2) The search of the genetic markers related to proteolytic systems that could determine the risk of suffering a recurrence in CAA.
We are studying a cohort of probable CAA patients that have been recruited in Hospital Vall d’Hebron in collaboration with the Stroke Project of the Cerebrovascular Diseases Study Group (Spanish Society of Neurology).
3) The study of MMPs role in ß-amyloid stimulated vascular cells in vitro.
Cultured cells of the neurovascular unit are challenged with different ß-amyloid peptides and the implication of MMPs in ß-amyloid cleavage and cell toxicity are studied using cellular and molecular biology methodology.
For this purpose, we use the human cerebral endothelial cell line hCMEC/D3, primary cultures of human leptomeningeal smooth muscle cells and rat/mouse glial and neuronal cultures.
Thioflavin-S staining of fibillar ß-amyloid within brain vessels of CAA patient’s sections.
Related bibliography:
1) Hernández-Guillamon M, Delgado P, Ortega L, Pares M, Rosell A, García-Bonilla L, Fernández-Cadenas I, Borrell-Pagès M, Boada M, Montaner J. Neuronal TIMP-1 release accompanies astrocytic MMP-9 secretion and enhances astrocyte proliferation induced by beta-amyloid 25-35 fragment. J Neurosci Res. 2009 Jul;87(9):2115-25.
2) Rosell A, Ortega-Aznar A, Alvarez-Sabín J, Fernández-Cadenas I, Ribó M, Molina CA, Lo EH, Montaner J. Increased brain expression of matrix metalloproteinase-9 after ischemic and hemorrhagic human stroke. Stroke. 2006 Jun;37(6):1399-406.
3) Alvarez-Sabín J, Delgado P, Abilleira S, Molina CA, Arenillas J, Ribó M, Santamarina E, Quintana M, Monasterio J, Montaner J. Temporal profile of matrix metalloproteinases and their inhibitors after spontaneous intracerebral hemorrhage: relationship to clinical and radiological outcome. Stroke. 2004 Jun;35(6):1316-22.
4) Montaner J, Molina CA, Monasterio J, Abilleira S, Arenillas JF, Ribó M, Quintana M, Alvarez-Sabín J. Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke. Circulation. 2003 Feb 4;107(4):598-603.
Collaborations:
Mercè Boada
Fundació ACE, Barcelona, Spain.
www.fundacioace.com/
Jorge Ghiso and Agueda Rostagno
Pathology Dept. Langone Medical Center. NYU
New York, US.
Ignacio Romero
Life Science Dept. Open University.
Milton Keynes, UK.
IP: Maria Mar Hernandez Guillamon
IP: Ariadna Laguna Tuset Collaborators: Anna Santamaria Margalef, Maria Mar Hernandez Guillamon, Sara Mas Assens Funding agency: Fundación Española Ciencia y Tecnología (FECYT) Funding: 15000 Reference: FCT-23-19804 Duration: 01/09/2024 - 31/08/2025
IP: Anna Rosell Novel Collaborators: Anna Penalba Morenilla, Kerrie Adrián Campbell, Miguel García Gabilondo Funding agency: Fundació La Marató de TV3 Funding: 173750 Reference: 202333-30 Duration: 22/04/2024 - 21/04/2027
IP: Jose Fernando Rodríguez Palomares Collaborators: Guillem Casas Masnou, Ruperto Olivero Soldevila, Alicia Fresno González, Javier Limeres Freire, Lydia Dux-Santoy Hurtado, Laura Fruitós Montané, Raul Aguilar Lopez, Miguel García Gabilondo Funding agency: Instituto de Salud Carlos III Funding: 200000 Reference: PI23/01397 Duration: 01/01/2024 - 31/12/2026
IP: Maria Mar Hernandez Guillamon Collaborators: Berta Paez Montserrat, Kerrie Adrián Campbell, Jessica Camacho Soriano, Anas Chaachou Charradi, Olalla Pancorbo Rosal Funding agency: Instituto de Salud Carlos III Funding: 208750 Reference: PI23/00082 Duration: 01/01/2024 - 31/12/2026
PMID: 36912140 Journal: STROKE Year: 2023 Reference: Stroke. 2023 Mar 13. doi: 10.1161/STROKEAHA.122.041839. Impact factor: Publication type: Letter whit IF Authors: Bernardino, Liliana; Cristovao, Ana; Ferreira, Lino; Ferreira, Raquel; Francisco, Vitor; Garcia-Gabilondo, Miguel; Grayston, Alba; Machado-Pereira, Marta; Marto, Joao; Rosell, Anna et al. DOI: 10.1161/STROKEAHA.122.041839
PMID: 37021149 Journal: European Stroke Journal Year: 2023 Reference: Eur Stroke J. 2023 Mar;8(1):309-319. doi: 10.1177/23969873221145391. Epub 2022 Dec 21. Impact factor: Publication type: Paper in international publication Authors: Arnold, Marcel; Arnold, Markus; Bicvic, Antonela; Bonati, Leo H; Bracher, Katja; Bustamante, Alejandro; Cereda, Carlo; De Marchis, Gian Marco; Fischer, Urs; Foerch, Christian et al. DOI: 10.1177/23969873221145391
PMID: 37026458 Journal: STROKE Year: 2023 Reference: Stroke. 2023 May;54(5):1289-1299. doi: 10.1161/STROKEAHA.122.040529. Epub 2023 Apr 7. Impact factor: Publication type: Paper in international publication Authors: Gorey, Sarah; Harris, Katie; Hervella, Pablo; Iglesias-Rey, Ramon; Jern, Christina; Kelly, Peter J; Li, Linxin; McCabe, John J; Miyamoto, Nobukazu; Montaner, Joan et al. DOI: 10.1161/STROKEAHA.122.040529
PMID: 37036702 Journal: JAMA Neurology Year: 2023 Reference: JAMA Neurol. 2023 Apr 10. doi: 10.1001/jamaneurol.2023.0611. Impact factor: Publication type: Paper in international publication Authors: Abraira, Laura; Alvarez-Sabin, Jose; Baumann, Christian R; Bayona-Ortiz, Hernan; Bentes, Carla; Bicciato, Giulio; Brigo, Francesco; Conrad, Julian; Dohler, Nico; Duncan, John S et al. DOI: 10.1001/jamaneurol.2023.0611
PMID: 35508915 Journal: EUROPEAN JOURNAL OF HEART FAILURE Year: 2022 Reference: Eur J Heart Fail. 2022 Jul;24(7):1253-1265. doi: 10.1002/ejhf.2525. Epub 2022 May 16. Impact factor: Publication type: Paper in international publication Authors: Abboud, C S; Abd El-Nasser, M; Abdel-Hay, M; Abdelnaby, M; Abe, K; Abid, L; Aboal Vinas, J; Aboulenein, J; Aboyans, V; Abreu, J et al. DOI: 10.1002/ejhf.2525
PMID: 34514662 Journal: BRAIN PATHOLOGY Year: 2022 Reference: Brain Pathol. 2022 Jan;32(1):e13016. doi: 10.1111/bpa.13016. Epub 2021 Sep 12. Impact factor: 6.508 Publication type: Paper in international publication Authors: Camacho, Jessica; Rabano, Alberto; Marazuela, Paula; Bonaterra-Pastra, Anna; Serna, Garazi; Moline, Teresa; Ramon Y Cajal, Santiago; Martinez-Saez, Elena; Hernandez-Guillamon, Mar et al. DOI: 10.1111/bpa.13016
PMID: 34687043 Journal: ACTA NEUROLOGICA SCANDINAVICA Year: 2022 Reference: Acta Neurol Scand. 2022 Feb;145(2):239-248. doi: 10.1111/ane.13543. Epub 2021 Oct 22. Impact factor: 3.209 Publication type: Paper in international publication Authors: Fonseca, Elena; Quintana, Manuel; Seijo-Raposo, Ivan; Ortiz de Zarate, Zurine; Abraira, Laura; Santamarina, Estevo; Toledo, Manuel; Alvarez-Sabin, Jose et al. DOI: 10.1111/ane.13543
PMID: 34988947 Journal: ACTA NEUROLOGICA BELGICA Year: 2022 Reference: Acta Neurol Belg. 2022 Jun;122(3):823-825. doi: 10.1007/s13760-021-01864-2. Epub 2022 Jan 6. Impact factor: 2.396 Publication type: Letter or abstract Authors: Lallana, Sofia; Sanchez-Tejerina, Daniel; Auger, Cristina; Callejo, Ana; Rio, Jordi; Cobo-Calvo, Alvaro et al. DOI: 10.1007/s13760-021-01864-2
PMID: 35083225 Journal: Frontiers in Cell and Developmental Biology Year: 2021 Reference: Front Cell Dev Biol. 2022 Jan 10;9:826037. doi: 10.3389/fcell.2021.826037. eCollection 2021. Impact factor: 6.684 Publication type: Review in international publication Authors: Coccia, Elena, Sole, Montse, Comella, Joan X et al. DOI: 10.3389/fcell.2021.826037
PMID: 34899582 Journal: Frontiers in Neurology Year: 2021 Reference: Front Neurol. 2021 Nov 25;12:767484. doi: 10.3389/fneur.2021.767484. eCollection 2021. Impact factor: 4.003 Publication type: Paper in international publication Authors: Tejada, Pedro Ignacio, Garcia-Rodriguez, Nicolas, Rodriguez, Susana, Buxo, Xavi, Perez-Mesquida, Maria Engracia, Beseler, Maria Rosario, Salom, Juan B, Perez, Laura M, Inzitari, Marco, Otero-Villaverde, Sergio et al. DOI: 10.3389/fneur.2021.767484
PMID: 34901817 Journal: Epilepsy & behavior reports Year: 2021 Reference: Epilepsy Behav Rep. 2021 Nov 14;16:100504. doi: 10.1016/j.ebr.2021.100504. eCollection 2021. Impact factor: 0 Publication type: Paper in international publication Authors: Abraira, L, Salas-Puig, J, Quintana, M, Seijo-Raposo, I M, Santamarina, E, Fonseca, E, Toledo, M et al. DOI: 10.1016/j.ebr.2021.100504
PMID: 34857668 Journal: Journal of NeuroInterventional Surgery Year: 2021 Reference: J Neurointerv Surg. 2021 Dec 2. pii: neurintsurg-2021-018241. doi: 10.1136/neurintsurg-2021-018241. Impact factor: 5.836 Publication type: Paper in international publication Authors: Olive-Gadea, Marta, Requena, Manuel, Diaz, Facundo, Boned, Sandra, Garcia-Tornel, Alvaro, Muchada, Marian, Deck, Matias, Lozano, Prudencio, Rodriguez-Villatoro, Noelia, Juega, Jesus et al. DOI: 10.1136/neurintsurg-2021-018241
PMID: 33173895 Journal: Year: 2020 Reference: medRxiv. 2020 Nov 3:2020.10.29.20222257. doi: 10.1101/2020.10.29.20222257. Preprint. Impact factor: Publication type: Other (letters to the editor, abstracts, corrigendum, etc.) Authors: Amini, Hajar; Ander, Bradley P; Arauz, Antonio; Arenillas, Juan Francisco; Arias-Rivas, Susana; Bang, Oh Young; Barboza, Miguel A; Bergmann, Kristy; Bradley, Joseph; Budde, John et al. DOI: 10.1101/2020.10.29.20222257
PMID: 33153769 Journal: NEUROLOGIA Year: 2020 Reference: Neurologia. 2020 Nov 2. pii: S0213-4853(20)30291-7. doi: 10.1016/j.nrl.2020.07.025. Impact factor: 2.283 Publication type: Review in national publication Authors: Rodriguez-Luna, D, Sanjuan, E, Pancorbo, O, Santana, K, Minarro, O, Sala, V, Muchada, M, Boned, S, Juega, J M, Pagola, J et al. DOI: 10.1016/j.nrl.2020.07.025
PMID: 33146036 Journal: CEPHALALGIA Year: 2020 Reference: Cephalalgia. 2020 Nov;40(13):1410-1421. doi: 10.1177/0333102420965157. Impact factor: 4.868 Publication type: Paper in international publication Authors: Caronna, Edoardo, Ballve, Alejandro, Llaurado, Arnau, Gallardo, Victor Jose, Maria Ariton, Diana, Lallana, Sofia, Maza, Samuel Lopez, Gadea, Marta Olive, Quibus, Laura, Restrepo, Juan Luis et al. DOI: 10.1177/0333102420965157
PMID: 33129044 Journal: EPILEPSY & BEHAVIOR Year: 2020 Reference: Epilepsy Behav. 2020 Dec;113:107511. doi: 10.1016/j.yebeh.2020.107511. Epub 2020 Oct 24. Impact factor: 2.508 Publication type: Paper in international publication Authors: Olive-Gadea, Marta, Quintana, Manuel, Abraira, Laura, Seijo-Raposo, Ivan, Santamarina, Estevo, Toledo, Manuel, Fonseca, Elena, Campos-Fernandez, Daniel et al. DOI: 10.1016/j.yebeh.2020.107511
PMID: 30506559 Journal: ACTA NEUROLOGICA SCANDINAVICA Year: 2019 Reference: Acta Neurol Scand. 2019 Apr;139(4):360-368. doi: 10.1111/ane.13059. Epub 2018 Dec 27. Impact factor: 2.852 Publication type: Paper in international publication Authors: Villanueva, Vicente, Lopez-Gonzalez, Francisco Javier, Mauri, Jose Angel, Rodriguez-Uranga, Juan, Olive-Gadea, Marta, Montoya, Javier, Ruiz-Gimenez, Jesus, Zurita, Jorge, Abril, J, Toledo, M et al. DOI: 10.1111/ane.13059
PMID: 31877821 Journal: Pharmaceutics Year: 2019 Reference: Pharmaceutics. 2019 Dec 21;12(1). pii: pharmaceutics12010016. doi: 10.3390/pharmaceutics12010016. Impact factor: 4.773 Publication type: Paper in international publication Authors: Rosell, Anna, Zhang, Yajie, Garcia-Gabilondo, Miguel, Roig, Anna et al. DOI: 10.3390/pharmaceutics12010016
PMID: 31777209 Journal: Emergencias Year: 2019 Reference: Emergencias. 2019 Dic;31(6):385-390. Impact factor: 3.35 Publication type: Paper in international publication Authors: Sanjuan Menendez, Estela, Giron Espot, Pilar, Calleja Macho, Laura, Rodriguez-Samaniego, Maria Teresa, Santana Roman, Katherine E, Rubiera Del Fueyo, Marta et al. DOI:
PMID: 30565357 Journal: EUROPEAN JOURNAL OF NEUROLOGY Year: 2019 Reference: Eur J Neurol. 2019 May;26(5):760-e55. doi: 10.1111/ene.13885. Epub 2019 Jan 20. Impact factor: 4.621 Publication type: Paper in international publication Authors: Requena, Manuel, Fonseca, Elena, Olive, Marta, Abraira, Laura, Quintana, Manuel, Mazuela, Gonzalo, Toledo, Manuel, Salas-Puig, Xavier, Santamarina, Estevo et al. DOI: 10.1111/ene.13885
PMID: 29194113 Journal: CLINICAL NEUROPHARMACOLOGY Year: 2018 Reference: Clin Neuropharmacol. 2018 Jan/Feb;41(1):6-9. doi: 10.1097/WNF.0000000000000258. Impact factor: 1.37 Publication type: Paper in international publication Authors: Toledo, Manuel, Ortega, Gemma, Abraira, Laura, Marti, Gloria, Quintana, Manuel, Mazuela, Gonzalo, Santamarina, Estevo, Salas-Puig, Xavier et al. DOI: 10.1097/WNF.0000000000000258
PMID: 30384104 Journal: EPILEPSY & BEHAVIOR Year: 2018 Reference: Epilepsy Behav. 2018 Dec;89:8-14. doi: 10.1016/j.yebeh.2018.09.046. Epub 2018 Oct 26. Impact factor: 2.6 Publication type: Paper in international publication Authors: Santamarina, Estevo, Parejo, Beatriz, Abraira, Laura, Gutierrez-Viedma, Alvaro, Alpuente, Alicia, Abarrategui, Belen, Toledo, Manuel, Mazuela, Gonzalo, Salas-Puig, Xavier, Garcia-Morales, Irene et al. DOI: 10.1016/j.yebeh.2018.09.046
PMID: 30334955 Journal: MEDICINE Year: 2018 Reference: Medicine (Baltimore). 2018 Oct;97(42):e12703. doi: 10.1097/MD.0000000000012703. Impact factor: 2.028 Publication type: Paper in international publication Authors: Cao, Junguo, Lei, Ting, Zhang, Chaochao, Ma, Chengyuan, Huang, Haiyan, Chen, Fan et al. DOI: 10.1097/MD.0000000000012703
PMID: 30172139 Journal: SEIZURE-EUROPEAN JOURNAL OF EPILEPSY Year: 2018 Reference: Seizure. 2018 Oct;61:158-163. doi: 10.1016/j.seizure.2018.08.016. Epub 2018 Aug 18. Impact factor: 2.839 Publication type: Clinical guide Authors: Toledo, M, Salas Puig, X, Abraira Del Fresno, L, Fonseca Hernandez, E, Olive Gadea, M, Requena Ruiz, M, Quintana, M, Santamarina Perez, E, Alvarez Sabin, J et al. DOI: 10.1016/j.seizure.2018.08.016
PMID: 28029607 Journal: Journal of Stroke & Cerebrovascular Diseases Year: 2017 Reference: J Stroke Cerebrovasc Dis. 2017 Feb;26(2):425-430. doi: 10.1016/j.jstrokecerebrovasdis.2016.10.004. Epub 2016 Oct 28. Impact factor: Publication type: Paper in international publication Authors: Arenillas, Juan F; Campos, Francisco; Cortes, Jordi; Davalos, Antoni; de la Ossa, Natalia Perez; Dorado, Laura; Gomis, Meritxell; Hernandez-Perez, Maria; Lopez-Cancio, Elena; Millan, Monica et al. DOI: 10.1016/j.jstrokecerebrovasdis.2016.10.004
PMID: 29116115 Journal: Scientific Reports Year: 2017 Reference: Sci Rep. 2017 Nov 7;7(1):14637. doi: 10.1038/s41598-017-15215-w. Impact factor: 4.259 Publication type: Paper in international publication Authors: Fernandez-de-Retana, Sofia, Cano-Sarabia, Mary, Marazuela, Paula, Sanchez-Quesada, Jose Luis, Garcia-Leon, Annabel, Montanola, Alex, Montaner, Joan, Maspoch, Daniel, Hernandez-Guillamon, Mar et al. DOI: 10.1038/s41598-017-15215-w
PMID: 28941727 Journal: NEUROBIOLOGY OF AGING Year: 2017 Reference: Neurobiol Aging. 2017 Dec;60:116-128. doi: 10.1016/j.neurobiolaging.2017.08.028. Epub 2017 Sep 5. Impact factor: 5.117 Publication type: Paper in international publication Authors: Fernandez-de Retana, Sofia, Montanola, Alex, Marazuela, Paula, De La Cuesta, Maialen, Batlle, Aina, Fatar, Marc, Grudzenski, Saskia, Montaner, Joan, Hernandez-Guillamon, Mar et al. DOI: 10.1016/j.neurobiolaging.2017.08.028
PMID: 28716979 Journal: STROKE Year: 2017 Reference: Stroke. 2017 Sep;48(9):2419-2425. doi: 10.1161/STROKEAHA.117.017076. Epub 2017 Jul 17. Impact factor: 6.032 Publication type: Paper in international publication Authors: Cardona, Pedro, Cano, Luis, Quesada, Helena, Terceno, Mikel, Silva, Yolanda, Castellanos, Mar, Garces, Moises, Reverte, Silvia, Ustrell, Xavier, Mares, Rafael et al. DOI: 10.1161/STROKEAHA.117.017076
PMID: 27311989 Journal: Archivos de la Sociedad Espanola de Oftalmologia Year: 2016 Reference: Arch Soc Esp Oftalmol. 2016 Nov;91(11):513-519. doi: 10.1016/j.oftal.2016.05.001. Epub 2016 Jun 13. Impact factor: 0 Publication type: Paper in national publication Authors: Vazquez Dorrego, X M, Manresa Dominguez, J M, Heras Tebar, A, Fores, R, Girona Marce, A, Alzamora Sas, M T, Delgado Martinez, P, Riba-Llena, I, Ugarte Anduaga, J, Beristain Iraola, A et al. DOI: 10.1016/j.oftal.2016.05.001
PMID: 25966945 Journal: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM Year: 2016 Reference: J Cereb Blood Flow Metab. 2016 Jan;36(1):253-63. doi: 10.1038/jcbfm.2015.90. Impact factor: 5.407 Publication type: Paper in international publication Authors: Montaner, Joan, Riba-Llena, Iolanda, Nafria, Cristina, Filomena, Josefina, Tovar, Jose L, Vinyoles, Ernest, Mundet, Xavier, Jarca, Carmen I, Vilar-Bergua, Andrea, Delgado, Pilar et al. DOI: 10.1038/jcbfm.2015.90
PMID: 25899297 Journal: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM Year: 2016 Reference: J Cereb Blood Flow Metab. 2016 Jan;36(1):55-71. doi: 10.1038/jcbfm.2015.68. Impact factor: 5.407 Publication type: Paper in international publication Authors: Vilar-Bergua, A, Riba-Llena, I, Nafria, C, Bustamante, A, Llombart, V, Delgado, P, Montaner, J et al. DOI: 10.1038/jcbfm.2015.68
PMID: 27956564 Journal: NEUROLOGY Year: 2016 Reference: Neurology. 2016 Dec 13;87(24):2533-2539. Epub 2016 Nov 9. Impact factor: 8.166 Publication type: Paper in international publication Authors: Vilar-Bergua, Andrea, Riba-Llena, Iolanda, Penalba, Anna, Jimenez-Balado, Joan, Montaner, Joan, Delgado, Pilar, Cruz, Luz Maria et al. DOI: 10.1212/WNL.0000000000003423
PMID: 26597154 Journal: Journal of the American Heart Association Year: 2015 Reference: J Am Heart Assoc. 2015 Nov 23;4(11). pii: JAHA.115.002669. doi: 10.1161/JAHA.115.002669. Impact factor: 4.306 Publication type: Paper in international publication Authors: Delgado, Pilar, Montaner, Joan, Libert, Claude, Vilar-Bergua, Andrea, Riba-Llena, Iolanda, Vanhooren, Valerie, Dewaele, Sylviane, Penalba, Anna et al. DOI: 10.1161/JAHA.115.002669
PMID: 26043763 Journal: International Journal of Stroke Year: 2015 Reference: Int J Stroke. 2015 Oct;10 Suppl A100:18-24. doi: 10.1111/ijs.12543. Epub 2015 Jun 4. Impact factor: 3.833 Publication type: Paper in international publication Authors: Riba-Llena, Iolanda, Koek, Marcel, Verhaaren, Benjamin F J, Vrooman, Henri A, van der Lugt, Aad, Hofman, Albert, Ikram, M Arfan, Vernooij, Meike W et al. DOI: 10.1111/ijs.12543
PMID: 25765726 Journal: STROKE Year: 2015 Reference: Stroke. 2015 May;46(5):1187-95. doi: 10.1161/STROKEAHA.114.008311. Epub 2015 Mar 12. Impact factor: 5.723 Publication type: Review in international publication Authors: Etgen, Thorleif, Llombart, Victor, Antolin-Fontes, Albert, Bustamante, Alejandro, Giralt, Dolors, Rost, Natalia S, Furie, Karen, Shibazaki, Kensaku, Biteker, Murat, Castillo, Jose et al. DOI: 10.1161/STROKEAHA.114.008311
PMID: 26101344 Journal: HYPERTENSION Year: 2015 Reference: Hypertension. 2015 Sep;66(3):634-40; discussion 445. doi: 10.1161/HYPERTENSIONAHA.115.05440. Epub 2015 Jun 22. Impact factor: 6.48 Publication type: Paper in international publication Authors: Filomena, Josefina, Tovar, Jose L, Mundet, Xavier, Castane, Xavier, Vilar, Andrea, Lopez-Rueda, Antonio, Jimenez-Balado, Joan, Cartanya, Anna, Montaner, Joan, Delgado, Pilar et al. DOI: 10.1161/HYPERTENSIONAHA.115.05440
PMID: 25463126 Journal: ATHEROSCLEROSIS Year: 2014 Reference: Atherosclerosis. 2014 Dec;237(2):811-5. doi: 10.1016/j.atherosclerosis.2014.11.003. Epub 2014 Nov 10. Impact factor: 3.971 Publication type: Paper in international publication Authors: Riba-Llena, Iolanda, Penalba, Anna, Pelegri, Dolors, Vilar, Andrea, Jarca, Carme I, Filomena, Josefina, Montaner, Joan, Delgado, Pilar et al. DOI: 10.1016/j.atherosclerosis.2014.11.003
PMID: 24958500 Journal: HYPERTENSION Year: 2014 Reference: Hypertension. 2014 Sep;64(3):658-63. doi: 10.1161/HYPERTENSIONAHA.114.03563. Epub 2014 Jun 23. Impact factor: 7.632 Publication type: Clinical Trials Authors: Delgado, Pilar, Riba-Llena, Iolanda, Tovar, Jose L, Jarca, Carmen I, Mundet, Xavier, Lopez-Rueda, Antonio, Orfila, Francesc, Llussa, Judit, Manresa, Josep M, Alvarez-Sabin, Jose et al. DOI: 10.1161/HYPERTENSIONAHA.114.03563
PMID: 24661059 Journal: J NEUROCHEM Year: 2014 Reference: J Neurochem. 2014 Jul;130(2):301-12. doi: 10.1111/jnc.12719. Epub 2014 Apr 30. Impact factor: 4.244 Publication type: Paper in international publication Authors: Campos-Martorell, Mireia, Salvador, Nelida, Monge, Marta, Canals, Francesc, Garcia-Bonilla, Lidia, Hernandez-Guillamon, Mar, Ayuso, Maria Irene, Chacon, Pilar, Rosell, Anna, Alcazar, Alberto et al. DOI: 10.1111/jnc.12719
PMID: 23556447 Journal: PHARMACOGENOMICS Year: 2013 Reference: Pharmacogenomics. 2013 Apr;14(5):495-504. doi: 10.2217/pgs.13.19. Impact factor: 3.857 Publication type: Paper in international publication Authors: Fernandez-Cadenas, Israel, Rio-Espinola, Alberto Del, Domingues-Montanari, Sophie, Mendioroz, Maite, Fernandez-Morales, Jessica, Penalba, Anna, Rubiera, Marta, Hernandez-Guillamon, Mar, Rosell, Anna, Delgado, Pilar et al. DOI: 10.2217/pgs.13.19
PMID: 23329208 Journal: STROKE Year: 2013 Reference: Stroke. 2013 Apr;44(4):e42. doi: 10.1161/STROKEAHA.112.681817. Epub 2013 Jan 17. Impact factor: 6.158 Publication type: Letter whit IF Authors: Riba-Llena, Iolanda, Montaner, Joan, Delgado, Pilar et al. DOI: 10.1161/STROKEAHA.112.681817
PMID: 23280790 Journal: ANNALS OF NEUROLOGY Year: 2012 Reference: Ann Neurol. 2012 Nov;72(5):716-29. doi: 10.1002/ana.23664. Impact factor: 11.089 Publication type: Paper in international publication Authors: Mendioroz, Maite, del Rio-Espinola, Alberto, Fernandez-Cadenas, Israel, Giralt, Dolors, Quiroga, Adoracion, Gutierrez-Agullo, Maria, Quintana, Manuel, Fernandez-Alvarez, Patricia, Domingues-Montanari, Sophie, Canovas, D et al. DOI: 10.1002/ana.23664
PMID: 22836018 Journal: JOURNAL OF THE NEUROLOGICAL SCIENCES Year: 2012 Reference: J Neurol Sci. 2012 Nov 15;322(1-2):79-81. doi: 10.1016/j.jns.2012.06.015. Epub 2012 Jul 24. Impact factor: 2.353 Publication type: Paper in international publication Authors: Riba, I, Jarca, C I, Mundet, X, Tovar, J L, Orfila, F, Nafria, C, Raga, A, Girona, A, Fernandez-Lara, P, Castane, X et al. DOI: 10.1016/j.jns.2012.06.015
PMID: 22548274 Journal: JOURNAL OF NEUROCHEMISTRY Year: 2012 Reference: J Neurochem. 2012 Jul;122(2):233-43. doi: 10.1111/j.1471-4159.2012.07773.x. Epub 2012 May 21. Impact factor: 4.061 Publication type: Review in international publication Authors: , , , , , , , et al. DOI: 10.1111/j.1471-4159.2012.07773.x
PMID: 22178747 Journal: CEREBROVASCULAR DISEASES Year: 2012 Reference: Cerebrovasc Dis. 2012;33(2):150-8. Epub 2011 Dec 14. Impact factor: 2.723 Publication type: Paper in international publication Authors: , , , , , , , , , et al. DOI: 10.1159/000334193
PMID: 21198992 Journal: JOURNAL OF INTERNAL MEDICINE Year: 2011 Reference: J Intern Med. 2011 Aug;270(2):166-74. doi: 10.1111/j.1365-2796.2010.02329.x. Epub 2010 Dec 27. Impact factor: 5.935 Publication type: Paper in international publication Authors: , , , , , , , , , et al. DOI: 10.1111/j.1365-2796.2010.02329.x
PMID: 21122033 Journal: EUROPEAN JOURNAL OF NEUROLOGY Year: 2011 Reference: Eur J Neurol. 2011 Jun;18(6):826-35. doi: 10.1111/j.1468-1331.2010.03243.x. Epub 2010 Dec 1. Impact factor: 3.765 Publication type: Paper in international publication Authors: , , , , , , , , , et al. DOI: 10.1111/j.1468-1331.2010.03243.x
PMID: 21131223 Journal: DIABETES & METABOLISM Year: 2011 Reference: Diabetes Metab. 2011 Apr;37(2):124-30. Epub 2010 Dec 4. Impact factor: 3.033 Publication type: Paper in international publication Authors: , , , , , , , et al. DOI: 10.1016/j.diabet.2010.08.006
PMID: 21620406 Journal: ATHEROSCLEROSIS Year: 2011 Reference: Atherosclerosis. 2011 Sep;218(1):181-7. Epub 2011 May 5. Impact factor: 4.086 Publication type: Paper in international publication Authors: , , , , , , , , , et al. DOI: 10.1016/j.atherosclerosis.2011.04.031
PMID: 24323553 Journal: Translational stroke research Year: 2010 Reference: Transl Stroke Res. 2010 Dec;1(4):261-7. doi: 10.1007/s12975-010-0038-0. Epub 2010 Aug 28. Impact factor: 0 Publication type: Paper in international publication Authors: Montaner, Joan, Salat, David, Garcia-Berrocoso, Teresa, Molina, Carlos A, Chacon, Pilar, Ribo, Marc, Alvarez-Sabin, Jose, Rosell, Anna et al. DOI: 10.1007/s12975-010-0038-0
PMID: 20402757 Journal: EUROPEAN JOURNAL OF NEUROLOGY Year: 2010 Reference: Eur J Neurol. 2010 Nov;17(11):1390-2. Impact factor: 2.51 Publication type: Paper in international publication Authors: , , , , , , , , , et al. DOI: 10.1111/j.1468-1331.2010.03022.x
PMID: 19420283 Journal: JOURNAL OF PARENTERAL AND ENTERAL NUTRITION Year: 2009 Reference: JPEN J Parenter Enteral Nutr. 2009 Sep-Oct;33(5):501-12. Impact factor: 1.97 Publication type: Paper in international publication Authors: Puiggros, C, Sanchez, J, Chacon, P, Sabin, P, Bou, R, Planas, M, Rosello, J et al. DOI: 10.1177/0148607109333001
PMID: 19694195 Journal: JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM Year: 2009 Reference: J Pediatr Endocrinol Metab. 2009 Jun;22(6):487-92. Impact factor: 0.938 Publication type: Paper in international publication Authors: Yeste, Diego, Chacon, Pilar, Clemente, Maria, Albisu, M A, Gussinye, Miquel, Carrascosa, Antonio et al. DOI:
PMID: 19531751 Journal: JOURNAL OF RHEUMATOLOGY Year: 2009 Reference: J Rheumatol. 2009 Aug;36(8):1639-45. Impact factor: 3.282 Publication type: Paper in international publication Authors: Urquizu-Padilla, Maria, Balada, Eva, Chacon, Pilar, Perez, Eduardo Hermosilla, Vilardell-Tarres, Miquel, Ordi-Ros, Josep et al. DOI: 10.3899/jrheum.081097
PMID: 19494488 Journal: CEREBROVASCULAR DISEASES Year: 2009 Reference: Cerebrovasc Dis. 2009;28(1):95-102. Impact factor: 3.041 Publication type: Paper in international publication Authors: Arenillas, Juan F, Massot, Andreu, Alvarez-Sabin, Jose, Fernandez-Cadenas, Israel, del Rio-Espinola, Albert, Chacon, Pilar, Quintana, Manuel, Molina, Carlos A, Rovira, Alex, Montaner, Joan et al. DOI: 10.1159/000222660
PhD student: Jara Cárcel Marquez Director/s: Israel Fernandez Cadenas University: Universitat Autònoma de Barcelona Year: 2023
PhD student: Anna Bonaterra Pastra, Anna Bonaterra Pastra Director/s: Maria Mar Hernandez Guillamon University: Year: 2023
PhD student: Elena Pala Vila Director/s: Joan Montaner Villalonga, Alejandro Bustamante Rangel University: Universidad Autònoma de Barcelona Year: 2022
PhD student: Julia Faura Llorens Director/s: Alejandro Bustamante Rangel, Joan Montaner Villalonga University: Universidad Autònoma de Barcelona Year: 2021
PhD student: Ting Lei (Santiago) Director/s: Anna Rosell Novel University: Universidad Autònoma de Barcelona Year: 2021
PhD student: Paula Marazuela Fuentes Director/s: Maria Mar Hernandez Guillamon University: Universidad Autònoma de Barcelona Year: 2021
PhD student: Joan Jimenez Balado Director/s: Maria Pilar Delgado Martínez University: Universidad Autònoma de Barcelona Year: 2020
PhD student: Gloria Monts. González Cuevas Director/s: Estevo Santamarina Pérez University: Universidad Autònoma de Barcelona Year: 2020
PhD student: Yajie Zhang Director/s: Anna Rosell Novel University: Universidad Autònoma de Barcelona Year: 2020
PhD student: Sofia Fernandez De Re Alda Director/s: Maria Mar Hernandez Guillamon University: Universidad Autònoma de Barcelona Year: 2018
PhD student: Marina Gabriel Salazar Director/s: Anna Rosell Novel University: Universidad Autònoma de Barcelona Year: 2018
PhD student: Alba Simats Oriol Director/s: Joan Montaner Villalonga, Teresa Garcia Berrocoso University: Universidad Autònoma de Barcelona Year: 2018
PhD student: Nuria Lacuey Lecumberri, Nuria Lacuey Lecumberri, Nuria Lacuey Lecumberri Director/s: José Alvarez Sabin University: Universidad Autònoma de Barcelona Year: 2018
PhD student: Mª Socorro Piñeiro Santos Director/s: José Alvarez Sabin, David Rodriguez Luna, Carlos Molina Cateriano University: Universidad Autònoma de Barcelona Year: 2017
PhD student: Andrea Vilar Bergua Director/s: Maria Pilar Delgado Martínez University: Universidad Autònoma de Barcelona Year: 2016
PhD student: Alejandro Bustamante Rangel Director/s: Joan Montaner Villalonga, Carlos Molina Cateriano University: Universidad Autònoma de Barcelona Year: 2016
PhD student: Victor Llombart Sebastià Director/s: Joan Montaner Villalonga, Maria Mar Hernandez Guillamon University: Universitat de Barcelona Year: 2016
PhD student: Cristina Merino Zamorano Director/s: Joan Montaner Villalonga University: Universidad Autònoma de Barcelona Year: 2016
PhD student: Yolanda Riba Llena Director/s: Joan Montaner Villalonga, Maria Pilar Delgado Martínez University: Universidad Autònoma de Barcelona Year: 2015
PhD student: Feifei Ma Director/s: Joan Montaner Villalonga, Anna Rosell Novel University: Universidad Autònoma de Barcelona Year: 2015
PhD student: Anna Morancho Retana Director/s: Anna Rosell Novel, Joan Montaner Villalonga University: Universidad Autònoma de Barcelona Year: 2014
PhD student: Teresa Garcia Berrocoso Director/s: Joan Montaner Villalonga, Israel Fernandez Cadenas, Maria Pilar Delgado Martínez University: Universidad Autònoma de Barcelona Year: 2014
PhD student: Mireia Campos Martorell Director/s: Joan Montaner Villalonga, Maria Mar Hernandez Guillamon University: Universidad Autònoma de Barcelona Year: 2014
PhD student: Elisa Carenza Director/s: Anna Rosell Novel University: Universidad Autònoma de Barcelona Year: 2014
PhD student: Maria Pilar Delgado Martínez Director/s: University: Universidad Autònoma de Barcelona Year: 2006
PhD student: Israel Fernandez Cadenas Director/s: University: Universidad Autònoma de Barcelona Year: 2006
PhD student: Anna Rosell Novel Director/s: University: Universidad Autònoma de Barcelona Year: 2005
PhD student: Juan Francisco Arenillas Lara Director/s: University: Universidad Autònoma de Barcelona Year: 2003
The TOUCH MSCA-COFUND doctoral training programme, led by UAB and focusing on the field of mental health, has opened its first call for applications, offering 13 doctoral positions.
The Cardiovascular Diseases and Neurovascular Diseases groups at VHIR will investigate new therapeutic strategies for heart failure, nanomedicine in stroke and the prevention of cardiovascular toxicity in the case of oncological treatments.
La recerca és fonamental per contrarestar els efectes de la pol·lució, que segons l’AEMPS, va ser la causa de més de 300.000 morts prematures a la UE el 2020.